Article
Biochemical mechanism of HIV-1 resistance to rilpivirine.
The Journal of biological chemistry - 2 Nov 2012
Singh Kamalendra, Marchand Bruno, Rai Devendra K, Sharma Bechan, Michailidis Eleftherios, Ryan Emily M, Matzek Kayla B, Leslie Maxwell D, Hagedorn Ariel N, Li Zhe, Norden Pieter R, Hachiya Atsuko, Parniak Michael A, Xu Hong-Tao, Wainberg Mark A, Sarafianos Stefan G
Abstract excerpt
Rilpivirine (RPV) is a second generation nonnucleoside reverse transcriptase (RT) inhibitor (NNRTI) that efficiently inhibits HIV-1 resistant to first generation NNRTIs. Virological failure during therapy with RPV and emtricitabine is associated with the appearance of E138K and M184I mutations in RT. Here we investigate the biochemical mechanism of RT inhibition and resistance to RPV. We used two transient...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
